This UroGen Pharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

Scotiabank analyst Allan Verkhovski initiated coverage on Paylocity Holding Corporation PCTY with a Sector Perform rating and announced a price target of $190. Paylocity shares closed at $186.75 on Tuesday. See how other analysts view this stock.
Chardan Capital analyst Keay Nakae initiated coverage on Korro Bio, Inc. KRRO with a Buy rating and announced a price target of $25. Korro Bio shares closed at $13.40 on Tuesday. See how other analysts view this stock.
Scotiabank initiated coverage on CG Oncology, Inc. CGON with a Sector Perform rating and announced a price target of $23. CG Oncology shares closed at $20.11 on Tuesday. See how other analysts view this stock.
Scotiabank initiated coverage on UroGen Pharma Ltd. URGN with a Sector Outperform rating and announced a price target of $23. UroGen Pharma shares closed at $10.75 on Tuesday. See how other analysts view this stock.
Scotiabank analyst George Farmer initiated coverage on Protara Therapeutics, Inc. TARA with a Sector Outperform rating and announced a price target of $12. Protara Therapeutics shares closed at $4.17 on Tuesday. See how other analysts view this stock.

Considering buying URGN stock? Here’s what analysts think:

Start Futures Trading Fast — with a $200 Bonus

Join Plus500 today and get up to $200 to start trading real futures. Practice with free paper trading, then jump into live markets with lightning-fast execution, low commissions, and full regulatory protection.